MedPath

Reaching for Equity in Sleep Apnea Treatment (REST) Study

Not Applicable
Recruiting
Conditions
Sleep Apnea
Interventions
Behavioral: Health coaching
Registration Number
NCT04209985
Lead Sponsor
University of California, San Francisco
Brief Summary

This study will test a brief telephonic health coaching intervention to improve adherence to positive airway pressure therapy for treatment of obstructive sleep apnea.

Detailed Description

The investigators will carry out a pilot study in which patients will be randomly assigned to receive health coaching or usual care. Participants are English- and Spanish-speaking patients from a county-based public health system who have received a positive airway pressure device for the treatment of sleep apnea. An unlicensed, trained health coach will call patients three times to resolve barriers to adherence. Primary outcomes include both adherence measures collected by the device modem at baseline and 4 months, and patient-reported outcomes such as daytime sleepiness.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • English- or Spanish-speaking
  • At least 18 years of age
  • Had previously received a modem-enabled positive airway pressure device for the treatment of sleep apnea
  • Not currently meeting Medicare standards for adherence of at least 4 hours per night for at least 70% of the last 30 nights
  • Received care from the San Francisco General Hospital Sleep Clinic
Read More
Exclusion Criteria
  • Not English- or Spanish-speaking
  • Younger than 18 years
  • Does not have phone number at which could be reached
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Health coaching armHealth coachingFor the health coaching arm, an unlicensed, trained health coach will call patients up to five times to identify and resolve barriers to adherence, including lack of understanding of their condition or the treatment, discomfort in acclimating to treatment, technical difficulties in mask fit or device settings, and challenges in navigating durable medical equipment providers.
Primary Outcome Measures
NameTimeMethod
Mean number of hours used on average over the last 30 daysEnrollment to 4 months post enrollment

Total number of hours PAP device used during 30 day period divided by 30 days (PAP device is part of existing clinical care)

Secondary Outcome Measures
NameTimeMethod
Attitudes to PAP treatmentEnrollment to 4 months post enrollment

Mean score on the Attitudes to PAP Treatment Inventory (5 items with combined scale of 4-25, where higher scores indicate negative attitudes toward PAP treatment)

Proportion using device at any time in last 30 daysEnrollment to 4 months post enrollment

Numerator: Number of people using PAP device at any time in last 30 days; Denominator: Number of people in study arm (PAP device is part of existing clinical care)

Patient-reported daytime sleepinessEnrollment to 4 months post enrollment

Mean score on the Epworth Sleepiness Scale (8 items with aggregate scale of 0-24 points, where 24 indicates greatest sleepiness symptoms)

Confidence in using PAP therapyEnrollment to 4 months post enrollment

Mean score on self-efficacy for use of PAP therapy (4 items, with combined scale from 0-40, where 40 indicates greatest self-efficacy)

Mean number of hours used on average over the last 30 days on nights that device was usedEnrollment to 4 months post enrollment

Total number of hours device used during 30 day period divided by the number of days on which the device was used

Mean proportion of last 30 days in which device used at least 4 hours/nightEnrollment to 4 months post enrollment

Mean across group of: (Numerator: Number of days in last 30 days that PAP device was used at least 4 hours; Denominator: 30 days) (PAP device is part of existing clinical care)

Trial Locations

Locations (1)

Zuckerberg San Francisco General Hospital Sleep Clinic

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath